University of Utah at SITC 2026
Nov 4–8, 2026 Phoenix, AZ ~6k attendees Website
University of Utah brings 7 presentations to SITC 2026 in Phoenix. Its program centres on engineering CAR receptors for finer control and on real-world immunotherapy outcomes in uveal, acral and mucosal melanoma. One concrete item links adding a liver perfusion procedure to immunotherapy with longer disease control in metastatic uveal melanoma.
| Organization | SITC 2026 Attendance |
|---|---|
University of Utah Salt Lake City, UT | |
A public research university. | Poster Fri Nov 6 12:15–1:45pm 5:30–7pm Poster Fri Nov 6 12:15–1:45pm 5:30–7pm Poster Fri Nov 6 12:15–1:45pm 5:30–7pm Poster Fri Nov 6 12:15–1:45pm 5:30–7pm Poster Sat Nov 7 12:30–1:30pm 6:40–8:10pm Poster Sat Nov 7 12:30–1:30pm 6:40–8:10pm Poster Sat Nov 7 12:30–1:30pm 6:40–8:10pm |
Instantly find 20 buyers from University of Utah
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by the Society for Immunotherapy of Cancer (SITC). Submit a correction